Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis

Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline

(2017) Cristoforo Comi et al.   JOURNAL OF ALZHEIMERS DISEASE

Circulating immune cells in multiple sclerosis

(2016) A. P. Jones et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

(2016) Massimo Filippi et al.   LANCET NEUROLOGY

Bias in Peripheral Depression Biomarkers

(2016) André F. Carvalho et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Biomarkers in multiple sclerosis

(2015) William J. Housley et al.   CLINICAL IMMUNOLOGY

Osteopontin in Immune-mediated Diseases

(2015) S.R. Rittling et al.   JOURNAL OF DENTAL RESEARCH

Role of the innate and adaptive immune responses in the course of multiple sclerosis

(2015) Bernhard Hemmer et al.   LANCET NEUROLOGY

Body fluid biomarkers for multiple sclerosis—the long road to clinical application

(2015) Charlotte E. Teunissen et al.   Nature Reviews Neurology

Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel

(2015) Morten Stilund et al.   PLoS One

Osteopontin as a therapeutic target for cancer

(2014) Monalisa Bandopadhyay et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis

(2014) G. Murugaiyan et al.   JOURNAL OF IMMUNOLOGY

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status

(2014) Violaine K. Harris et al.   Molecular Diagnosis & Therapy

Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial

(2014) J. Romme Christensen et al.   NEUROLOGY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis

(2013) Pietro Iaffaldano et al.   BRAIN BEHAVIOR AND IMMUNITY

Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barré Syndrome

(2013) Rong kun Han et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica

(2013) Yuko Shimizu et al.   JOURNAL OF NEUROIMMUNOLOGY

Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity

(2013) Levente Szalardy et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Body fluid biomarkers in multiple sclerosis

(2013) Manuel Comabella et al.   LANCET NEUROLOGY

BAFF maintains T-cell survival by inducing OPN expression in B cells

(2013) Ning Ma et al.   MOLECULAR IMMUNOLOGY

Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development

(2013) Pia Kivisäkk et al.   Multiple Sclerosis Journal

Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers

(2013) Mohsen Khademi et al.   PLoS One

A Pattern Approach to Focal White Matter Hyperintensities on Magnetic Resonance Imaging

(2013) Sangam Kanekar et al.   RADIOLOGIC CLINICS OF NORTH AMERICA

The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression

(2012) Cristoforo Comi et al.   Clinical & Developmental Immunology

Osteopontin regulates interleukin-17 production in hepatitis

(2012) Hongyan Diao et al.   CYTOKINE

Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients

(2012) Shi-Rong Wen et al.   JOURNAL OF NEUROIMMUNOLOGY

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

(2012) Jeppe Romme Christensen et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Patterns of Th1/Th2 Cytokines Predict Clinical Response in Multiple Sclerosis Patients Treated with Glatiramer Acetate

(2011) Hayrettin Tumani et al.   EUROPEAN NEUROLOGY

Diagnosis of Multiple Sclerosis

(2011) Barbara S. Giesser   NEUROLOGIC CLINICS

Correlation of Circulating Omentin-1 with Bone Mineral Density in Multiple Sclerosis: The Crosstalk between Bone and Adipose Tissue

(2011) Majid Assadi et al.   PLoS One

Differences between Human Plasma and Serum Metabolite Profiles

(2011) Zhonghao Yu et al.   PLoS One

Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers

(2010) Mario HJ Vogt et al.   Multiple Sclerosis Journal

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis

(2010) Lars Börnsen et al.   Multiple Sclerosis Journal

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers

(2009) M. Khademi et al.   EUROPEAN JOURNAL OF NEUROLOGY

The role of osteopontin in inflammatory processes

(2009) Susan Amanda Lund et al.   Journal of Cell Communication and Signaling

Increased Osteopontin Levels in the Cerebrospinal Fluid of Patients With Multiple Sclerosis

(2008) Manjit Braitch et al.   ARCHIVES OF NEUROLOGY

Specificity and Correlation With Disease Activity of Cerebrospinal Fluid Osteopontin Levels in Patients With Multiple Sclerosis

(2008) Soheli A. Chowdhury et al.   ARCHIVES OF NEUROLOGY

The role of osteopontin: A shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?

(2008) Ayse Altıntaş et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES